Treating a Patient with Cannabis Use Disorder. Disclosures. Three Areas of Focus 4/9/2018. Grants from NIDA, World Health Organization.
|
|
- Abraham Thompson
- 5 years ago
- Views:
Transcription
1 Treating a Patient with Cannabis Use Disorder Kevin P. Hill, M.D., M.H.S. 41 st Annual Governor s Conference on Substance Abuse, Des Moines IA 4/19/18 Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center khill1@ bidmc.harvard.edu, Disclosures Grants from NIDA, World Health Organization. Book- Hazelden Publishing. Three Areas of Focus Clinical work: Director of Addiction Psychiatry, private practice, pro sports teams and leagues. Clinical research: cannabis clinical trials. Educational outreach: Science vs. public perception, schools, policymakers. 1
2 Why Cannabis? Addiction treatment: 40% alcohol, 40% opioids, 20% everything else. Around 60%: time when smoked cannabis daily for years. How many of these folks would you see down the road if an effective cannabis intervention existed? In The Middle National Statistics: Not Going Away About 22 million Americans used cannabis in the past year, use doubled in past 10 years (Hasin et al. 2015). Powerful messages medical marijuana, legalization, celebrities. Most messages off the mark, contribute to gap between science and public perception. 2
3 Current Trends in Cannabis Use Compton, Lancet Psychiatry (2016) Pharmacology of Cannabis 100+ pharmacologicallyactive cannabinoids. THC: euphoria, antiinflammatory, psychosis. CBD: non-psychoactive, anti-anxiety, antipsychotic? Potency Rising 60s, 70s, 80s: avg THC content 3-4%. Now: avg THC content 12% (ElSohly 2016). BUT you can get cannabis (plant not oil) in the 20s and low 30s. 3
4 Other Forms of Cannabis Treatment Cannabis Treatment Access and Utilization Only 6% of those seeking substance abuse treatment sought treatment for cannabis use disorder. Most people do not think cannabis use requires treatment. No generally accepted treatments. 4
5 Diagnosis Preparation. Conversation. Evaluation. Referral. How to have the Conversation 5
6 What to Look for Social problems caused by or worsened by cannabis. Gives up important activities. Use in dangerous situations. Use despite obvious physical, psychological problems. Thorough Evaluation Motivational interviewing. Careful history. Alliance. Recommendations. What does treatment look like? Medical detox not necessary. 30 days of rehab is unlikely. Get prospective patient to talk to somebody. Readiness/alliance work/family support. Medication if appropriate. 6
7 Challenges Patients not coming on their own accord. Public and peer perception of cannabis addictiveness and harm. The rest of my life Having to give up something you enjoy, often when your peers are not. Case: Rick Rick, a 29-year-old software engineer, has used daily for years. He says it helps him relax and manage anxiety. He doesn t see his cannabis use as a big problem, but his wife does. She is frustrated by the time he spends smoking and feels he needs to grow up. They have discussed having their first child and she cannot see herself having a child with him if he is using cannabis every day. Case: Rick Approach? Positive Prognostic Indicators? Potential Barriers? 7
8 Behavioral Interventions Why Use? Enhance recreational activity. Relax/escape. Anxiety. Insomnia. CBT Approach After initial Motivational Interviewing Different smoking situations, different thought processes. Alternatives while acknowledging the differences. Challenging automatic thoughts, etc. 8
9 Medications for Cannabis Use Disorder No FDA-Approved Medications Meds plus therapy paradigm. NAC, gabapentin. What would happen to these patients if there was an effective medication available? 9
10 N-acetylcysteine Antioxidant, glutamate modulator. Gray (AJP, 2012): NAC plus contingency management participants 2.4x more likely to produce THC-negative urine. 1200mg twice a day, no titration. Drowsiness, nausea, GI upset- minor overall. GABA modulator. Gabapentin Mason et al. (2012): 1200mg twice a day X 12 weeks. Reduced use (biochemical and self-report) and withdrawal symptoms. Our Cannabis Clinical Trials Nabilone. (Hill et al. AJA 2017) Dronabinol and clonidine in patients with significant mental illness. Cannabidiol. 10
11 Case: Rick Weekly psychotherapy: CBT. Continue SSRI, add NAC 1200 mg twice daily. Marijuana Anonymous. Clinically-significant reduction (but not abstinence). Treatment Outcomes Self-report. Biochemical verification, lab data. Active participation in adjunct treatments. Collateral from family or other treaters. Summary Use good clinical principles to make a diagnosis. No consensus treatments. Labor intensive, but these patients do get better. 11
12 Acknowledgments Matt Palastro Questions? 12
A Conversation: Marijuana and Youth
A Conversation: Marijuana and Youth Kevin P. Hill, M.D., M.H.S. North Shore Community College, 9/28/17 Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center khill1@ bidmc.harvard.edu,
More informationMarijuana and the Chronic Non-Cancer Pain Patient
Marijuana and the Chronic Non-Cancer Pain Patient Kevin P. Hill, M.D., M.H.S. Pain 101: Provider Workshop 9/23/16 McLean Hospital Division of Alcohol and Drug Abuse khill@mclean.harvard.edu DrKevinHill.com,
More informationCannabis Use: Scope of the Issue
Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationMarijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine
Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for
More informationMarijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM
Marijuana DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationCannabis for Medical Use: Body and Mind
Cannabis for Medical Use: Body and Mind Shaul Schreiber, MD Division of Psychiatry, Tel Aviv Sourasky Medical Center; Tel Aviv University Sackler Faculty of Medicine; Sagol School of Neuroscience, Israel
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationManagement of Marijuana Addiction
Management of Marijuana Addiction Martha T. Kane, PhD Clinical Director, Center for Addiction Medicine Associate Director, Ambulatory Psychiatry Massachusetts General Hospital Does marijuana addiction
More informationLegalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine
Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics
More informationWELCOME TO THEORY WELLNESS PATIENTS. Committed to wellbeing through cannabis.
WELCOME TO THEORY WELLNESS PATIENTS Committed to wellbeing through cannabis. Focused on small batches and unique genetics, we strive to develop a premium range of strains and products for consumers in
More informationWELCOME TO THEORY WELLNESS CUSTOMERS. Committed to wellbeing through cannabis.
WELCOME TO THEORY WELLNESS CUSTOMERS Committed to wellbeing through cannabis. Focused on small batches and unique genetics, we strive to develop a premium range of strains and products for consumers in
More informationMedicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose
Medicinal Cannabis Patient Log Book Record your cannabis use and find the right dose 1 Introduction A federal system is in place for medicinal cannabis that is distinct from recreational sales. To get
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationTreating Pain and Depression
Treating Pain and Depression Without Getting Depressed Joseph P, Arpaia, MD www.jparpaiamd.com More than 50% of patients with chronic pain also have clinically significant depression. Interestingly that
More informationMedical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.
Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure
More informationMarijuana Science Update
Marijuana Science Update Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse ADVANCING ADDICTION SCIENCE NIDA CANNABIS SCIENCE RESEARCH AREAS EPIDEMIOLOGY: National and Local
More informationMarijuana and Adolescent Brain Development
Marijuana and Adolescent Brain Development Amy Turncliff, PhD June 2016 Acknowledgements: Slides contributed by Ruth Potee MD, Bertha Madras PhD, John Scheft Esq, and Heidi Heilman. Maturation of the human
More informationCannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety
Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety The use of medical marijuana continues to be an emotionally and politically charged issue. Although cannabis oil preparations have been
More informationMinnesota, Marijuana and Myths
3M: Minnesota, Marijuana and Myths Ken Winters, Ph.D. Senior Scientist Oregon Research Institute & Adjunct Faculty, Dept. of Psychology University of Minnesota winte001@umn.edu April 26, 2018 Curious How
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationAssessing and Treating Cooccurring
Assessing and Treating Cooccurring Mental Illness and SUD Joshua Boverman M.D. Medical Director, Wallowa Valley Center for Wellness Consulting Psychiatrist, Winding Waters Clinic Affiliate Assistant Professor
More informationMARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec
MARIJUANA in MEDICAL CARE READY or RISKY HINDI MERMELSTEIN, MD FAPM drhmermelstein @optimum.net Beth Israel Medical Center, NYC Dec 11 2015 HISTORY MARIJUANA (CANNABIS SAVITA) HAS LONG BEEN PART OF RELIGIOUS
More informationConsumer Information Cannabis (Marihuana, marijuana)
Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The
More informationIs the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young
The Facts Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and now as medicine. Marijuana also refers to
More informationMarijuana Education in a Post-Legalization Society Presented on October 31, 2017
Marijuana Education in a Post-Legalization Society Presented on October 31, 2017 by the Co-founder of the Marijuana Education Initiative Molly Lotz, LCSW Today we will be addressing adolescent perceptions
More informationAGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up
AGENDA 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up Marijuana: Preventing Youth Use Juliet D Alessandro, Healthy Communities Specialist Today
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationFree! Register now on Eventbrite
Sunday, November 18, 2018, 1-4pm Gates Middle School 460 First Parish Road, Scituate Free! Register now on Eventbrite Copy and Paste this Link https://www.eventbrite.com/e/power-of-prevention-summit-2018-tickets-51363003125
More informationThe ATTC Network LEARNING OBJECTIVES. Clinical Skills in the Era of Legal Cannabis. Clinical Skills in the Era of Legal Cannabis 6/30/2015
Clinical Skills in the Era of Legal Cannabis Jennifer Wyatt, LMHC, MT-BC, CDP: wyattj@ohsu.edu Northwest Institute of Addiction Studies Conference July 22, 2015: Clackamas, OR The ATTC Network Ten Regional
More informationCBD oil for Asthma. Use of Cannabis in Asthma
CBD oil for Asthma For several years, we have been working intensively on the mode of action of CBD. Through the regular use of CBD, in the production of CBD oil from various hemp varieties, through selfexperimentation,
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationClinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD
Clinical Education Initiative Support@ceitraining.org MEDICAL MARIJUANA 101 Speaker: Patricia Reed, PharmD 8/2/2017 Medical Marijuana 101 [video transcript] 00:00:12 - So we'll get started. Disclosures
More informationRates of Co-Occurring Disorders Among Youth. Working with Adolescents with Substance Use Disorders
1 Working with Adolescents with Substance Use Disorders Michael S. Levy, Ph.D. CAB Health & Recovery Services, Inc. Health and Education Services 8% of 12-17 year old youth have substance abuse or dependence
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationBENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU
BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU TABLE OF CONTENTS 4 Benzodiazepine Addiction 8 Xanax Withdrawal Symptoms 11 Professional Help for Benzo Withdrawal is Essential for Success 15 Relapse
More informationMarijuana in Pregnancy
Idaho Perinatal Project 2019 Winter Conference Marijuana in Pregnancy What are we telling our patients? Stacy T. Seyb, MD Kristy Schmidt, MN, RN, NEA-BC Special Thanks to Tori Metz, MD University of Utah
More informationLessons Learned. Marijuana Education & Prevention in Colorado
Lessons Learned Marijuana Education & Prevention in Colorado Jessica Neuwirth Retail Marijuana Education & Youth Prevention Coordinator, Prevention Services Division CDPHE ON Enact the will of the people
More informationCannabis Use Disorder: What Nurses Need to Know. Bari K Platter, MS, RN, PMHCNS-BC Clinical Nurse Specialist
Cannabis Use Disorder: What Nurses Need to Know Bari K Platter, MS, RN, PMHCNS-BC Clinical Nurse Specialist MARIJUANA POTENCY Average THC and CBD Levels in the U.S. 1960-2011 14 12 10 8 6 4 THC: Psychoactive
More informationCANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician
CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician AGENDA THC IMPAIRMENT A deep dive into THC vs. CBD Signs and
More informationMarijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration
Marijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration DISCLOSURES Employed by the Department of Veteran Affairs
More informationTHE HIDDEN SUBSTANCE ABUSE CRISIS. Mary Aldred-Crouch, MSW, MPH, LICSW, MAC, AADC
THE HIDDEN SUBSTANCE ABUSE CRISIS Mary Aldred-Crouch, MSW, MPH, LICSW, MAC, AADC TRAINING OBJECTIVES Substance Use Disorders a review Understand what is different with SUD in older adults So why is it
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.
More informationthe facts about BUPRENORPHINE for Treatment of Opioid Addiction
the facts about BUPRENORPHINE for Treatment of Opioid Addiction i I d been shot on the streets, I d been in detox. It was jails, institutions. Death, I knew, was imminent for me so I started my recovery
More informationMedical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University
Medical Cannabis use in the Older Patient Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Disclosure Relationships with commercial interests: Grants/Research Support: none Speakers
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationRalph Cantor Marijuana Berkeley City Council June 4, 2013
Ralph Cantor rjcantor@aol.com 510-653-9410 Marijuana Berkeley City Council June 4, 2013 What this talk is about! 1) Why is the use of marijuana and alcohol with teens amongst the highest here??? Availability
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationAction Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross
Action Potentials and Synaptic Transmission BIO 219 Napa Valley College Dr. Adam Ross Review of action potentials Nodes of Ranvier Nucleus Dendrites Cell body In saltatory conduction, the nerve impulses
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationCannabis derived terpenes for sale
Cannabis derived terpenes for sale Buy real weed online! Your premium edibles. Cannabis Oil. Canabidol CBD cannabis oil (CBD Oli) is derived from EU approved, UK & US legal, industrial hemp (Cannabis Sativa
More informationPREVENTING MARIJUANA USE AMONG YOUTH & YOUNG ADULTS
PREVENTING MARIJUANA USE AMONG YOUTH & YOUNG ADULTS PREVENTING MARIJUANA USE AMONG YOUTH & YOUNG ADULTS 2 The Drug Enforcement Administration s (DEA) primary mission and responsibility is to enforce the
More informationParent/Community Presentation Marijuana and the Adolescent Brain. Presented by. Ralph Cantor
Parent/Community Presentation Marijuana and the Adolescent Brain Presented by Ralph Cantor Introduction 1. Introduce myself; teacher (not a doctor),my use of models for understanding complexity 2. Understanding
More informationDISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,
More informationCBD & Hemp Oil: Cannabis, Cannabinoids And The Benefits Of Medical Marijuana By Aaron Hammond READ ONLINE
CBD & Hemp Oil: Cannabis, Cannabinoids And The Benefits Of Medical Marijuana By Aaron Hammond READ ONLINE CBD Hemp Oil Benefits & Properties; What is CBD The Cannabinoid in Hemp / Cannabis. CBD Hemp Oil
More information10 Questions to Ask. Before You Use Marijuana
10 Questions to Ask Before You Use Marijuana 1 You ve probably heard conflicting opinions about marijuana and its risks. The health information included here is based on recent studies done by researchers
More informationCannabinoids and Mental Health
Cannabinoids and Mental Health https://upload.wikimedia.org/wikipedia/commons Karen M. Lounsbury, PhD Professor of Pharmacology 802-656-3231, Karen.lounsbury@uvm.edu Objectives Describe the underlying
More informationHow can we optimise treatment of people who are cannabis dependent? Tom Freeman Clinical Psychopharmacology Unit University College London, UK
How can we optimise treatment of people who are cannabis dependent? Tom Freeman Clinical Psychopharmacology Unit University College London, UK Disclosure statement: I have no conflicts of interest Outline
More informationWhy Adolescents are at Risk for Substance Abuse and Addiction
Why Adolescents are at Risk for Substance Abuse and Addiction Ken Winters, Ph.D. Addiction Researcher winte001@umn.edu AARC Community Education & Prevention September 20, 2016 1. Brain development 4. How
More informationteen drug use Percent of 12th-graders Who Used A Substance in the Past Month (Type of Drug & Prevalence): 13% 33% 11% 23%
teen drug use As kids get older, they often start to question the life lessons they hear from parents and teachers. They become more heavily influenced by the things they see on TV, the Internet and social
More informationTrends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses. Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C
Trends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C 1 Marijuana/Cannabis Marijuana use is growing in popularity
More informationA Budding New Treatment? Cannabinoid Agonists for Cannabis Use Disorder
A Budding New Treatment? Cannabinoid Agonists for Cannabis Use Disorder Pharmacotherapy Grand Rounds Raeschell Shelly Williams, PharmD, MPH PGY2 Psychiatric Pharmacy Resident South Texas Veterans Health
More informationMedical Marijuana Myths and Realities
Medical Marijuana Myths and Realities Herbert D. Kleber, M.D. Professor of Psychiatry Director, Division on Substance Abuse Columbia University/NYSPI October 8, 2013 THS 2013 Biarritz Introduction Marijuana
More informationState-funded Marijuana Objectives
State-funded Marijuana Objectives Objectives funded by Maine Office of Substance Abuse and Mental Health Services (SAMHS) Increase communications to the public about the risk and harm of marijuana use
More informationCHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationThe Use of Sleep Aids in Our Society Today
The Use of Sleep Aids in Our Society Today Kathryn Hansen, BS, CPC, CPMA, REEGT Integration Consultants, LLC Sleep Education Partners Executive Director Kentucky Sleep Society Executive Director Society
More informationMARIJUANA & THE EFFECTS ON THE BRAIN
MARIJUANA & THE EFFECTS ON THE BRAIN Sheryl Ryan, MD Professor of Pediatrics Chief, Division of Adolescent Medicine, Penn State Health Hershey Medical Center DISCLOSURES I have no relevant financial relationships
More informationMedical Marijuana A Primer for Pharmacists
Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationHow does cannabis affect my work performance?
How does cannabis affect my work performance? How does cannabis affect my work performance? Driving skills and ability to operate machinery Using cannabis negatively affects your balance, coordination,
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationSynthetic cannabinoids: Flying high under the RADAR Brett Ginsburg, Ph.D.
Synthetic cannabinoids: Flying high under the RADAR Brett Ginsburg, Ph.D. Introduction Brett Ginsburg, Ph.D. Associate Professor Department of Psychiatry Introduction What are synthetic cannabinoids? Manufacture
More informationAddiction History. Patient Assessment. Objectives. Cost. Initial Screen. Patient Assessment 25/04/2017. Substances. Age Started
Addiction History Patient Assessment Methadone and Suboxone 2017 Dr. Morris Markentin, 2017 Substances Current substance use and amount Age Started Each substance Route of use each substance Inhalation
More information2018/05/01 DISCLOSURE EFFECTS OF CANNABIS USE IN ADOLESCENTS
DISCLOSURE EFFECTS OF CANNABIS USE IN ADOLESCENTS No conflict of interest to declare No pharmaceutical industry support No support from cannabis producers Selene Etches MD, FRCPC Cannabis is the most widely
More informationROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE
ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE You are a 58 year old man/woman and have a history of severe chronic low back pain for 20 years. You injured your back 20 years ago at work and have
More informationManaging presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead
Managing presenting problems with benzodiazepines By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead OUTLINE OF PRESENTATION Why Benzodiazepines (BDZ s) are used Mechanism of Action
More informationContingency Management with Adolescents and Their Families
+ Contingency Management with Adolescents and Their Families Evidencebased approach for treating adolescent substance abuse Promotes positive behaviors and addresses ambivalence Strength- Based, Family-
More informationCannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery
Cannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery Lisa Laitman MSEd, LCADC Rutgers, The State University of New Jersey National
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More informationCBD PURE OPIOID RECOVERY FORMULA 600mg Reduce Opioid withdrawal symptoms, Non-narcotic painkiller
OUR MISSION To ensure patients have access to consistently high quality therapeutic products rooted in science and not folklore WHAT ARE OUR GOALS? Produce high quality, tested and verified therapeutic
More informationWeeding Through the Science of Cannabis. Ryan Vandrey, PhD
Weeding Through the Science of Cannabis Ryan Vandrey, PhD What is Cannabis? Basic Plant Information Cannabis is a genus of plants with 3 species: Cannabis Sativa Cannabis Indica Cannabis Ruderalis Plant
More informationUse of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More information